News News March, 2021 IGM Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update Read More... March, 2021 IGM Biosciences to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Conference Call and Webcast on March 30, 2021 Read More... March, 2021 IGM Biosciences Appoints Lisa Decker, Ph.D., as Chief Business Officer Read More... February, 2021 IGM Biosciences to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day Read More... January, 2021 IGM Biosciences Enters into Exclusive Licensing Agreement with Medivir for Birinapant Read More... January, 2021 IGM Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference Read More... December, 2020 IGM Announces Closing of $230 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Read More... December, 2020 IGM Announces Pricing of Upsized $200 million Public Offering Read More... December, 2020 IGM Announces Proposed Public Offering Read More... December, 2020 IGM Biosciences Presents First Clinical Data from IGM-2323 in Non-Hodgkin’s Lymphoma at 2020 ASH Annual Meeting Read More... « Previous 1 2 3 4 … 6 Next »
